News

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...
AMPLITUDE is the “first trial to show efficacy for the combination of inhibition of PARP and the androgen receptor pathway in metastatic, castration-sensitive prostate cancer with alteration of genes ...
In the latest edition of "LC Troubleshooting", Dwight Stoll explores troubleshooting tips for liquid chromatography, ...
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...
Researchers from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, along with multiple ...
At the heart of Trade 350 App lies a proprietary AI engine that continuously learns and evolves. Rather than relying on ...
Researchers used machine learning and life cycle assessment to evaluate the carbon emissions of magnesium silicate hydrate ...